Clinical trials

  • Ponatinib for Acute lymphoblastic leukaemia (Philadelphia chromosome-positive, BCR-ABL+)
  • TREPROSTINIL for Progressive pulmonary fibrosis | Pulmonary fibrosis
  • BIMEKIZUMAB for Hidradenitis Suppurativa
  • OPEVESOSTAT TOSILATE for Metastatic castration-resistant prostate cancer
  • NIPOCALIMAB for Warm autoimmune hemolytic anemia
  • METHYL (1R,2S,3S,5S)-8-[(E)-4-(18F)FLUORANYLBUT-2-ENYL]-3-(4-METHYLPHENYL)-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE for Traumatic brain injury | Traumatic coma
  • EMRUSOLMIN for Multiple system atrophy
  • RILVEGOSTOMIG for HER2-expressing gastric cancer | HER2-expressing gastroesophageal junction (GEJ) adenocarcinoma | HER2-expressing esophageal adenocarcinoma
  • PASIREOTIDE DIASPARTATE for Post-bariatric hypoglycaemia
  • FINERENONE for Chronic kidney disease | Proteinuria
  • Humanised IgG1 monoclonal antibody against CD152 for Metastatic non-small cell lung cancer
  • VALGANCICLOVIR for Glioblastoma multiforme (WHO grade IV)